Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics (Q41472115)
Jump to navigation
Jump to search
scientific article published on 20 July 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics |
scientific article published on 20 July 2016 |
Statements
1 reference
Osteosarcoma cells with genetic signatures of BRCAness are susceptible to the PARP inhibitor talazoparib alone or in combination with chemotherapeutics (English)
1 reference
1 reference
Florian Engert
1 reference
Michal Kovac
1 reference
Daniel Baumhoer
1 reference
Michaela Nathrath
1 reference
1 reference
1 reference
Identifiers
1 reference